Potential role of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
Vicky Ren,1 Harry Dao Jr2 1Baylor College of Medicine , School of Medicine, 2Department of Dermatology, Baylor College of Medicine Houston, TX, USA Background: Psoriasis is a debilitating autoimmune skin disease that affects 2%–3% of the world's population. Patients with mo...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2013-03-01
|
| Series: | Clinical, Cosmetic and Investigational Dermatology |
| Online Access: | http://www.dovepress.com/potential-role-of-ixekizumab-in-the-treatment-of-moderate-to-severe-pl-a12470 |